LUMOS PHARMA, INC.·4

Jun 3, 4:52 PM ET

Schuchart Aaron 4

4 · LUMOS PHARMA, INC. · Filed Jun 3, 2021

Insider Transaction Report

Form 4
Period: 2021-06-01
Schuchart Aaron
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-01+7,8057,805 total
    Exercise: $10.13Exp: 2031-05-31Common Stock (7,805 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on July 1, 2021, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant.

Documents

1 file
  • 4
    wf-form4_162275349099019.xmlPrimary

    FORM 4